HIGHFDA DRUG

Carbamazepine Extended-Release 400 mg Tablets Recalled for Failed Dissolution Specifications (D-0675

FDA recalls Carbamazepine Extended-Release Tablets, 400 mg, distributed nationwide by American Health Packaging. The recall cites failed dissolution specifications and class II classification. Consumers should stop using and contact healthcare providers for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 15, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 15, 2025
Hazard Level
HIGH
Brands
Carbamazepine, American Health Packaging
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, PETS

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Carbamazepine, American Health Packaging
Product type
Carbamazepine Extended-Release Tablets 400 mg
Model numbers
Lot #: 1024078, Exp. Date 08/31/2026
UPC codes
60687-583, 60687-594, 60687-583-11, 60687-583-21, 60687-594-11, 60687-594-21
Sizes
400 mg
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 15, 2025

  2. Reported by FDA DRUG

    October 8, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Failed Dissolution Specifications.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Amerisource Health Services LLC or your healthcare provider for guidance. Notification method: Letter

About This Product

Carbamazepine extended-release tablets are used to treat seizures and nerve pain. This recall involves 360 cartons distributed nationwide.

Why This Is Dangerous

Failure to dissolve as specified can alter drug release and absorption, potentially impacting effectiveness and safety.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

The recall may affect adherence to prescribed therapy and require medical guidance for safe continuation.

Practical Guidance

How to identify if yours is affected

  1. Check carton NDC 60687-594-21
  2. Check Individual Dose NDC 60687-594-11
  3. Inspect Lot #1024078 and Exp. Date 08/31/2026
  4. Confirm 30 tablets per carton (3x10 cards)
  5. Confirm 360 cartons distributed nationwide

Where to find product info

On the carton and patient information leaflets; FDA enforcement page for D-0675-2025

What timeline to expect

Refund or replacement timelines will be provided in recall communications by Amerisource Health Services LLC and pharmacies

If the manufacturer is unresponsive

  • Document all communications
  • File a consumer complaint with the FDA recall search
  • Consult pharmacist for alternatives

How to prevent similar issues

  • Verify NDC and lot numbers before dispensing new prescriptions
  • Ask pharmacists about dissolution specifications and stability
  • Use approved pharmacies and verify shelf life at receipt

Documentation advice

Keep the recall notice, receipts, and any correspondence with healthcare providers or pharmacies

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Carbamazepine Extended-Release Tablets, USP 400 mg. 30 tablets per carton (3x10 unit dose cards). Rx Only. Distributor: American Health Packaging, Columbus, OH 43217. Carton NDC 60687-594-21; Individual Dose NDC 60687-594-11. Quantity: 360 cartons. Lot #: 1024078. Exp. Date: 08/31/2026. Sold nationwide in the USA. Generic name CARBAMAZEPINE; Brand CARBAMAZEPINE.

Reported Incidents

No injuries or incidents have been reported in the provided data.

Key Facts

  • Individual Dose NDC 60687-594-11
  • High-risk drug category (Rx only)

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTPETS
Injury Types
LACERATIONOTHER

Product Classification

Product Details

Model Numbers
Lot #: 1024078
Exp. Date 08/31/2026
UPC Codes
60687-583
60687-594
60687-583-11
+3 more
Affected States
ALL
Report Date
October 8, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

KVK-Tech Inc. Recalls Oxycodone Hydrochloride Tablets Over Seal Defects

KVK-Tech Inc. recalled 31,676 packages of Oxycodone Hydrochloride Tablets on January 14, 2026. Defective seals may cause tablets to fall out, posing a health risk. Customers should stop using the product immediately and seek guidance from healthcare providers.

OXYCODONE HYDROCHLORIDE
Defective container:
Read more